Insider · CIK 0001788919
Heinz Christoph Maeusli
Files at LNTH (Lantheus Holdings, Inc.). First filing -, latest -.
In brief
Heinz Christoph Maeusli files SEC Form 4 as director at LNTH (Lantheus Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Heinz Christoph Maeusli has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | LNTH Lantheus Holdings, Inc. | AGrant or award Common Stock | +4,137 | $0.00 | $0 | 30,014 | May 18, 2026 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Common Stock | +2,537 | $0.00 | $0 | 25,877 | May 16, 2025 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,543 | $0.00 | $0 | 4,543 | May 16, 2025 |
Questions about Heinz Christoph Maeusli
Answered from the filings on this page, as of the latest one.
Is Heinz Christoph Maeusli buying or selling?
Heinz Christoph Maeusli has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Heinz Christoph Maeusli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Heinz Christoph Maeusli has 0.
Where does Heinz Christoph Maeusli file Form 4?
Heinz Christoph Maeusli has filed Form 4 at LNTH (Lantheus Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.